IN

Iram Nabi Bhat

Active Director Director DIN 10898048
DIN 10898048 First appointment Jan 2025 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Iram Nabi Bhat

Data last updated:

Iram Nabi Bhat is a Director at Al Samad Remedies Private Limited (since 2025). The company operates in Research & Development.

DIN 10898048
Primary Designation Director
Industry Research & Development
First Appointment 06 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Al Samad Remedies Private Limited U73100JK2025PTC016824
Director06 Jan 20252025Active

Board colleagues of Iram Nabi Bhat

NameDINCompanyDesignation
Mubashir Mehraj10898047Al Samad Remedies Private LimitedDirector

Directorship timeline

Open interactive timeline →
Al Samad Remedies Private Limited
Premium access

Shareholding and investment profile for Iram Nabi Bhat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Iram Nabi Bhat

Iram Nabi Bhat currently holds 1 directorship: Al Samad Remedies Private Limited (Director, since 06 Jan 2025).

Iram Nabi Bhat was first appointed on 06 Jan 2025 as Director at Al Samad Remedies Private Limited.

The current boards of Iram Nabi Bhat's companies include Mubashir Mehraj (Al Samad Remedies Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available